These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1398500

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of loxiglumide, a cholecystokinin antagonist, on pancreatic polypeptide release in humans.
    Meier R, Hildebrand P, Thumshirn M, Albrecht C, Studer B, Gyr K, Beglinger C.
    Gastroenterology; 1990 Dec; 99(6):1757-62. PubMed ID: 2227288
    [Abstract] [Full Text] [Related]

  • 24. CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.
    Konturek JW, Konturek SJ, Kurek A, Bogdal J, Oleksy J, Rovati L.
    Gut; 1989 Aug; 30(8):1136-42. PubMed ID: 2767511
    [Abstract] [Full Text] [Related]

  • 25. Effect of a cholecystokinin receptor antagonist (loxiglumide) on gallbladder contractile function in guinea pigs.
    Tsubo K, Arai M, Omachi H, Mitamura K.
    J Gastroenterol; 1996 Aug; 31(4):578-81. PubMed ID: 8844481
    [Abstract] [Full Text] [Related]

  • 26. Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man.
    Jebbink MC, Jansen JB, Masclee AA, Lamers CB.
    Br J Clin Pharmacol; 1990 Jun; 29(6):770-3. PubMed ID: 2378793
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cholecystokinin is a regulator of intestinal phase-stimulated PP release.
    Adler G, Beglinger C, Braun U, Reinshagen M, Koop I, Schafmayer A.
    Regul Pept; 1990 Sep 10; 30(2):105-11. PubMed ID: 2274676
    [Abstract] [Full Text] [Related]

  • 29. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K, Saito T, Saeki M, Ninomiya K, Kasai H, Kimura K, Fujii M.
    Arzneimittelforschung; 1997 Oct 10; 47(10):1130-3. PubMed ID: 9368707
    [Abstract] [Full Text] [Related]

  • 30. Duodenal phytohaemagglutinin (red kidney bean lectin) stimulates gallbladder contraction in humans.
    Purhonen AK, Herzig KH, Gabius HJ, André S, Ketterer S, Matzinger D, Beglinger C, Hildebrand P.
    Acta Physiol (Oxf); 2008 Jul 10; 193(3):241-7. PubMed ID: 18248661
    [Abstract] [Full Text] [Related]

  • 31. Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin stimulated pancreatic enzyme secretion in man.
    Jebbink MC, Jansen JB, Mooy DM, Rovati LC, Lamers CB.
    Regul Pept; 1991 Feb 26; 32(3):361-8. PubMed ID: 1714084
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effect of intravenous glucose on intravenous amino acid-induced gallbladder contraction and CCK secretion.
    De Boer SY, Masclee AA, Lam WF, Jansen JB, Lamers CB.
    Dig Dis Sci; 1994 Feb 26; 39(2):268-74. PubMed ID: 8313807
    [Abstract] [Full Text] [Related]

  • 35. The effect of loxiglumide (CR-1505) on basal and bombesin-stimulated gallbladder volume in man.
    Douglas BR, Jebbink MC, Tjon a Tham RT, Jansen JB, Lamers CB.
    Eur J Pharmacol; 1989 Jul 18; 166(2):307-9. PubMed ID: 2792196
    [Abstract] [Full Text] [Related]

  • 36. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
    Lieverse RJ, Jansen JB, Masclee AA, Rovati LC, Lamers CB.
    Gut; 1994 Apr 18; 35(4):501-5. PubMed ID: 8174988
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hyperglycemia reduces gallbladder emptying and plasma hormone secretion to modified sham feeding and regular feeding.
    De Boer SY, Masclee AA, Lam WF, Schipper J, Jansen JB, Lamers CB.
    Hepatology; 1993 Jun 18; 17(6):1022-7. PubMed ID: 8514250
    [Abstract] [Full Text] [Related]

  • 39. Effect of endogenous cholecystokinin on postprandial gallbladder refilling. Ultrasonographic study in healthy subjects and in gallstone patients.
    Cicala M, Corazziari E, Diacinti D, Badiali D, Torsoli A.
    Dig Dis Sci; 1995 Jan 18; 40(1):76-81. PubMed ID: 7821124
    [Abstract] [Full Text] [Related]

  • 40. Gallbladder fasting volume is reduced and gallbladder postprandial emptying is enhanced by intravenous erythromycin.
    Tsiaoussis I, Xynos E, Tzovaras G, Chrysos E, Glynos M, Vassilakis JS.
    Dig Dis Sci; 1998 Jan 18; 43(1):178-82. PubMed ID: 9508522
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.